N-(4-Methyl-3-((1-nicotinoylazetidin-3-yl)methoxy)phenyl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide

ID: ALA3948993

Chembl Id: CHEMBL3948993

PubChem CID: 134147296

Max Phase: Preclinical

Molecular Formula: C31H34F3N5O3

Molecular Weight: 581.64

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1OCC1CN(C(=O)c2cccnc2)C1

Standard InChI:  InChI=1S/C31H34F3N5O3/c1-21-5-8-26(15-28(21)42-20-22-17-39(18-22)30(41)24-4-3-9-35-16-24)36-29(40)23-6-7-25(27(14-23)31(32,33)34)19-38-12-10-37(2)11-13-38/h3-9,14-16,22H,10-13,17-20H2,1-2H3,(H,36,40)

Standard InChI Key:  FEAKFWGIUURCKV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3948993

    ---

Associated Targets(Human)

KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCR/ABL BCR/ABL p210 fusion protein (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 581.64Molecular Weight (Monoisotopic): 581.2614AlogP: 4.56#Rotatable Bonds: 8
Polar Surface Area: 78.01Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 7.57CX LogP: 3.85CX LogD: 3.46
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.42Np Likeness Score: -1.71

References

1. Wang Q, Liu F, Wang B, Zou F, Qi Z, Chen C, Yu K, Hu C, Qi S, Wang W, Hu Z, Liu J, Wang W, Wang L, Liang Q, Zhang S, Ren T, Liu Q, Liu J..  (2017)  Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding.,  60  (1): [PMID:27966954] [10.1021/acs.jmedchem.6b01290]

Source